In a report of a serious advese event not forwarded to FDA, a 2019 complaint to Market America said its TLS 21-Day Challenge Kit “reported inpatient hospitalization was needed due to various adverse reactions."
Explore how consumer health is evolving. On the go.
David Ridley hosts in-depth conversations with industry leaders.
